Objective： To detect the retention of intron 9 in CD44 mRNA in cervical cancer tissue, CIN, cervicitis and their exfoliated cells, and to study their clinical significance in diagnosis and treatment of early-stage, n...Objective： To detect the retention of intron 9 in CD44 mRNA in cervical cancer tissue, CIN, cervicitis and their exfoliated cells, and to study their clinical significance in diagnosis and treatment of early-stage, non-invasive cervical cancer, Methods： RT-PCR methods were used to detect the retention of intron 9 in CD44 mRNA in 30 cases of cervical cancer tissue, 11 cases of CIN tissue, 30 cases of cervicitis tissue and their exfoliated cells. Results： The retention rate of intron 9 in CD44 gene transcripts were 76.7% in cervical cancer tissue, 89,8% in corresponding exfoliated cells, 70.8% in CIN tissue, and 60.0% in CIN exfoliated cells, but undetected in neither cervicitis tissue nor exfoliated cells. The relative quantity of intron 9 in CD44 gene transcripts was 1.10 ± 0.12 in cervical cancer tissue, 1.21 ± 0.11 in CIN tissue, 1.11 ± 0.19 in cervical cancer exfoliated cells, 1.17 ± 0.12 in CIN exfoliated cells respectively, but undetected in neither cervicitis tissue nor exfoliated cells. The retention rate and relative content of intron 9 in CD44 gene transcripts in cervical cancer and CIN tissue and their exfoliated cells were statistically higher than that in cervicitis and their exfoliated cells （P〈0.005）. There was statistic difference comparing the retention rate of intron 9 in CD44 gene mRNA transcripts （70.8%） with positive rate in cytology （40.0%） in cervical cancer （x^2=5.78, P〈0.05）, but no statistic difference between the retention rate of intron 9 in CD44 gene transcripts （60.0%） with positive rate in cytology （36.4%） in CIN （x^2=0.585, P〉0.05）. Conclusion： Detecting the retention of intron 9 in CD44 mRNA in cervical exfoliated cells was more sensitivity than traditional cytology exam for diagnosing cervical cancer, and the techniques was worth clinical application.展开更多
文摘Objective： To detect the retention of intron 9 in CD44 mRNA in cervical cancer tissue, CIN, cervicitis and their exfoliated cells, and to study their clinical significance in diagnosis and treatment of early-stage, non-invasive cervical cancer, Methods： RT-PCR methods were used to detect the retention of intron 9 in CD44 mRNA in 30 cases of cervical cancer tissue, 11 cases of CIN tissue, 30 cases of cervicitis tissue and their exfoliated cells. Results： The retention rate of intron 9 in CD44 gene transcripts were 76.7% in cervical cancer tissue, 89,8% in corresponding exfoliated cells, 70.8% in CIN tissue, and 60.0% in CIN exfoliated cells, but undetected in neither cervicitis tissue nor exfoliated cells. The relative quantity of intron 9 in CD44 gene transcripts was 1.10 ± 0.12 in cervical cancer tissue, 1.21 ± 0.11 in CIN tissue, 1.11 ± 0.19 in cervical cancer exfoliated cells, 1.17 ± 0.12 in CIN exfoliated cells respectively, but undetected in neither cervicitis tissue nor exfoliated cells. The retention rate and relative content of intron 9 in CD44 gene transcripts in cervical cancer and CIN tissue and their exfoliated cells were statistically higher than that in cervicitis and their exfoliated cells （P〈0.005）. There was statistic difference comparing the retention rate of intron 9 in CD44 gene mRNA transcripts （70.8%） with positive rate in cytology （40.0%） in cervical cancer （x^2=5.78, P〈0.05）, but no statistic difference between the retention rate of intron 9 in CD44 gene transcripts （60.0%） with positive rate in cytology （36.4%） in CIN （x^2=0.585, P〉0.05）. Conclusion： Detecting the retention of intron 9 in CD44 mRNA in cervical exfoliated cells was more sensitivity than traditional cytology exam for diagnosing cervical cancer, and the techniques was worth clinical application.
